Role of nebulized amphotericin b in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature

Rosaria Casciaro, Aldo Naselli, Federico Cresta, Mirco Ros, Elio Castagnola, Laura Minicucci

Research output: Contribution to journalArticle

Abstract

Objectives: To review the data available in literature about nebulized amphotericin B (AMB) in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) and to report our experience in the use of this drug, with a particular therapeutic scheme.  Case Report: We used nebulized liposomal amphotericin B (L-AMB) in a patient affected by CF, complicated by ABPA. The previous combined treatment with oral steroids and azoles had no respiratory benefit and caused relevant side effects. Amphotericin B has always been well tolerated and permitted a slight steroid tapering. We also observed benefits in pulmonary function and laboratory tests. Conclusions: Few data are available in literature about the use of nebulized AMB in CF and there are no RCTs evaluating antifungals in CF-ABPA. In our opinion, the reported case suggests that nebulized L-AMB could represent a possible strategy in ABPA management in CF patients.

Original languageEnglish
Pages (from-to)307-311
Number of pages5
JournalJournal of Chemotherapy
Volume27
Issue number5
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Allergic Bronchopulmonary Aspergillosis
Amphotericin B
Cystic Fibrosis
Steroids
Azoles
Respiratory Function Tests
Therapeutics
Pharmaceutical Preparations

Keywords

  • Amphotericin B
  • Antifungal therapy
  • Aspergillosis
  • Azole antifungals
  • Cystic fibrosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Oncology
  • Pharmacology

Cite this

Role of nebulized amphotericin b in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis : Case report and review of literature. / Casciaro, Rosaria; Naselli, Aldo; Cresta, Federico; Ros, Mirco; Castagnola, Elio; Minicucci, Laura.

In: Journal of Chemotherapy, Vol. 27, No. 5, 01.10.2015, p. 307-311.

Research output: Contribution to journalArticle

@article{6e0534cab0a14da7afba457085f6f605,
title = "Role of nebulized amphotericin b in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature",
abstract = "Objectives: To review the data available in literature about nebulized amphotericin B (AMB) in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) and to report our experience in the use of this drug, with a particular therapeutic scheme.  Case Report: We used nebulized liposomal amphotericin B (L-AMB) in a patient affected by CF, complicated by ABPA. The previous combined treatment with oral steroids and azoles had no respiratory benefit and caused relevant side effects. Amphotericin B has always been well tolerated and permitted a slight steroid tapering. We also observed benefits in pulmonary function and laboratory tests. Conclusions: Few data are available in literature about the use of nebulized AMB in CF and there are no RCTs evaluating antifungals in CF-ABPA. In our opinion, the reported case suggests that nebulized L-AMB could represent a possible strategy in ABPA management in CF patients.",
keywords = "Amphotericin B, Antifungal therapy, Aspergillosis, Azole antifungals, Cystic fibrosis",
author = "Rosaria Casciaro and Aldo Naselli and Federico Cresta and Mirco Ros and Elio Castagnola and Laura Minicucci",
year = "2015",
month = "10",
day = "1",
doi = "10.1179/1973947814Y.0000000194",
language = "English",
volume = "27",
pages = "307--311",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "5",

}

TY - JOUR

T1 - Role of nebulized amphotericin b in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis

T2 - Case report and review of literature

AU - Casciaro, Rosaria

AU - Naselli, Aldo

AU - Cresta, Federico

AU - Ros, Mirco

AU - Castagnola, Elio

AU - Minicucci, Laura

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objectives: To review the data available in literature about nebulized amphotericin B (AMB) in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) and to report our experience in the use of this drug, with a particular therapeutic scheme.  Case Report: We used nebulized liposomal amphotericin B (L-AMB) in a patient affected by CF, complicated by ABPA. The previous combined treatment with oral steroids and azoles had no respiratory benefit and caused relevant side effects. Amphotericin B has always been well tolerated and permitted a slight steroid tapering. We also observed benefits in pulmonary function and laboratory tests. Conclusions: Few data are available in literature about the use of nebulized AMB in CF and there are no RCTs evaluating antifungals in CF-ABPA. In our opinion, the reported case suggests that nebulized L-AMB could represent a possible strategy in ABPA management in CF patients.

AB - Objectives: To review the data available in literature about nebulized amphotericin B (AMB) in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) and to report our experience in the use of this drug, with a particular therapeutic scheme.  Case Report: We used nebulized liposomal amphotericin B (L-AMB) in a patient affected by CF, complicated by ABPA. The previous combined treatment with oral steroids and azoles had no respiratory benefit and caused relevant side effects. Amphotericin B has always been well tolerated and permitted a slight steroid tapering. We also observed benefits in pulmonary function and laboratory tests. Conclusions: Few data are available in literature about the use of nebulized AMB in CF and there are no RCTs evaluating antifungals in CF-ABPA. In our opinion, the reported case suggests that nebulized L-AMB could represent a possible strategy in ABPA management in CF patients.

KW - Amphotericin B

KW - Antifungal therapy

KW - Aspergillosis

KW - Azole antifungals

KW - Cystic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=84940027992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940027992&partnerID=8YFLogxK

U2 - 10.1179/1973947814Y.0000000194

DO - 10.1179/1973947814Y.0000000194

M3 - Article

C2 - 24824366

AN - SCOPUS:84940027992

VL - 27

SP - 307

EP - 311

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 5

ER -